Mark R. Prausnitz advances process-level drug and vaccine delivery across skin, eye and gastrointestinal routes, creating microneedle and oral platforms, intradermal electroporation and skin-based diagnostics, with emphasis on manufacturable materials, stability and regulatory translation for patient‑friendly care.